Insights

Hear Directly From Finovate Experts

Switzerland Is Revising Its Patent Act: What the Incoming Reforms Mean for Patent Landscape Strategy

When Your Competitor Files the Same Invalidity Arguments Twice: How to Build a Prior Art Case That Holds Up Under Repeat Attack

The UPC’s First FRAND Decision: What the Dolby v. Beko Ruling Means for SEP Licensing Negotiations

The Swiss Federal Patent Court’s Expedited Nullity Proceedings: What It Means for Pharma and MedTech IP Portfolios

The Rise of NPE Litigation: Why Non-Practicing Entities Are Targeting Mid-Market Companies — and How Proactive Infringement Monitoring Changes Your Defence

Why This Is Now One of the Most Valuable Patent Licensing Markets in the World — and How to Build a Strategy for It

Load More